Division of Plastic & Reconstructive Surgery, Stanford University School of Medicine, 770 Welch Road, Suite 400, Palo Alto, CA, 94304, USA.
Aesthetic Plast Surg. 2022 Apr;46(2):655-660. doi: 10.1007/s00266-021-02660-2. Epub 2021 Nov 29.
Shared decision-making gives patients greater autonomy in their healthcare decisions; however, decisions that result in negative outcomes may lead to decision regret. The complexity of reconstructive options makes post-mastectomy breast reconstruction particularly prone to decision regret. This study's purpose was to explore the relationship between breast reconstruction modalities and degree of postoperative decision regret. Patients who had undergone either implant-based or autologous breast reconstruction with a minimum of 12 months of follow-up were invited to complete the Decision Regret Scale and the BREAST-Q Satisfaction with Breasts module. The impact of reconstructive modality and occurrence of postoperative complications on decision regret and satisfaction with breasts was examined. Sixty-three patients completed the questionnaires-25 patients with implant-based reconstruction and 38 patients with autologous reconstruction. The average Decision Regret score was 84.6 ± 23.6; thirty-one patients experienced no decision regret. The average score for the BREAST-Q module was 81.9 ± 18.8. Neither satisfaction with breasts nor decision regret were impacted by the reconstructive modality. The occurrence of postoperative complications was strongly correlated with lower Decision Regret scores (91.6 vs. 74.6, p=0.004) but was not correlated with lower Satisfaction with Breasts scores (84.6 vs. 78.2, p=0.18). Patients had relatively low levels of decision regret and relatively high levels of satisfaction with breasts, irrespective of reconstructive modality. Having a postoperative complication led to significantly greater levels of decision regret without impacting satisfaction with breasts. Patients may benefit from additional preoperative education on possible complications to mitigate decision regret. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
患者在医疗决策中拥有更大的自主权,这是共同决策带来的结果;然而,这些决策可能导致负面结果,进而导致决策后悔。重建方案的复杂性使得乳房再造手术后更容易产生决策后悔。本研究旨在探讨乳房重建方式与术后决策后悔程度之间的关系。邀请接受过基于植入物或自体乳房重建术且随访时间至少 12 个月的患者完成决策后悔量表和 BREAST-Q 乳房满意度模块。检查了重建方式和术后并发症的发生对决策后悔和乳房满意度的影响。63 名患者完成了问卷,其中 25 名患者接受了基于植入物的重建,38 名患者接受了自体重建。决策后悔评分的平均值为 84.6±23.6,31 名患者没有决策后悔。BREAST-Q 模块的平均得分为 81.9±18.8。乳房满意度或决策后悔均不受重建方式的影响。术后并发症的发生与较低的决策后悔评分显著相关(91.6 比 74.6,p=0.004),但与较低的乳房满意度评分无关(84.6 比 78.2,p=0.18)。无论采用何种重建方式,患者的决策后悔水平相对较低,而对乳房的满意度相对较高。术后并发症的发生导致决策后悔显著增加,但对乳房满意度没有影响。患者可能受益于更多关于可能发生的并发症的术前教育,以减轻决策后悔。证据等级 IV:本杂志要求作者为每篇文章分配一个证据等级。有关这些循证医学等级的完整描述,请参考目录或在线作者指南 www.springer.com/00266。